Ignite Creation Date:
2025-12-24 @ 3:24 PM
Ignite Modification Date:
2026-01-21 @ 4:38 PM
Study NCT ID:
NCT03577392
Status:
UNKNOWN
Last Update Posted:
2019-04-04
First Post:
2018-06-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Recombinant Human Endostatin in Combination With XELOX Therapy in Patient With Advanced Colorectal Cancer.
Sponsor:
Sichuan Provincial People's Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SIM-ED-1512
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |